In vitro Activity of Meropenem-Vaborbactam versus Other Antibiotics Against Carbapenem-Resistant Escherichia coli from Southeastern China

Na Huang1 Department of Clinical Laboratory, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325035, Zhejiang Province, People’s Republic of China

Tao Chen1 Department of Clinical Laboratory, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325035, Zhejiang Province, People’s Republic of China

Liqiong Chen2 Department of Medical Lab Science, School of Laboratory Medicine and Life Science, Wenzhou Medical University, Wenzhou, 325035, Zhejiang Province, People’s Republic of China

Ying Zhang2 Department of Medical Lab Science, School of Laboratory Medicine and Life Science, Wenzhou Medical University, Wenzhou, 325035, Zhejiang Province, People’s Republic of China

Yishuai Lin2 Department of Medical Lab Science, School of Laboratory Medicine and Life Science, Wenzhou Medical University, Wenzhou, 325035, Zhejiang Province, People’s Republic of China

Xiangkuo Zheng1 Department of Clinical Laboratory, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325035, Zhejiang Province, People’s Republic of China

Tieli Zhou1 Department of Clinical Laboratory, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325035, Zhejiang Province, People’s Republic of China

Lijiang Chen1 Department of Clinical Laboratory, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325035, Zhejiang Province, People’s Republic of ChinaCorrespondence[email protected] [email protected]

show all

In vitro Activity of Meropenem-Vaborbactam versus Other Antibiotics Against Carbapenem-Resistant Escherichia coli from Southeastern China

Table 1 Minimum Inhibitory Concentrations (MICs) of 58 Carbapenem-Resistant Escherichia coli Isolates

Table 2 Percent Susceptible^a for Meropenem/Vaborbactam (MVB) and Comparator Agents in Relation to Different Separation Sites^b

Table 3 Percent Susceptible^a for Meropenem/Vaborbactam (MVB) and Comparator Agents in Relation to Individual Resistance Genes^b

Table 4 Combination of Resistance Mechanisms Among 58 Carbapenem-Resistant Escherichia coli Isolates

Table 5 Percent Susceptible^a for Meropenem/Vaborbactam (MVB) and Comparator in Relation to Sequence Types (STs)^b

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

In vitro Activity of Meropenem-Vaborbactam versus Other Antibiotics Against Carbapenem-Resistant Escherichia coli from Southeastern China

Figures & data

Table 1 Minimum Inhibitory Concentrations (MICs) of 58 Carbapenem-Resistant Escherichia coli Isolates

Table 2 Percent Susceptiblea for Meropenem/Vaborbactam (MVB) and Comparator Agents in Relation to Different Separation Sitesb

Table 3 Percent Susceptiblea for Meropenem/Vaborbactam (MVB) and Comparator Agents in Relation to Individual Resistance Genesb

Table 4 Combination of Resistance Mechanisms Among 58 Carbapenem-Resistant Escherichia coli Isolates

Table 5 Percent Susceptiblea for Meropenem/Vaborbactam (MVB) and Comparator in Relation to Sequence Types (STs)b

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Table 2 Percent Susceptible^a for Meropenem/Vaborbactam (MVB) and Comparator Agents in Relation to Different Separation Sites^b

Table 3 Percent Susceptible^a for Meropenem/Vaborbactam (MVB) and Comparator Agents in Relation to Individual Resistance Genes^b

Table 5 Percent Susceptible^a for Meropenem/Vaborbactam (MVB) and Comparator in Relation to Sequence Types (STs)^b